All News

From the first annual Glioblastoma Awareness Day to politics and today’s top performers, here’s what’s making headlines in the cancer space this week.​

We've got a sneak peek at what’s inside CURE®'s lung cancer special issue.

A small molecule drug may help to overcome resistance to Imbruvica in patients with MCL, according to preclinical study findings from The University of Texas MD Anderson Cancer Center.

May is recognized as Bladder Cancer Awareness Month. Know the facts and statistics in order to understand your risk for the disease and take preventative actions to guard your health.

A diagnosis of cancer is completely overwhelming and something most of us are not prepared for. It may be easy to think about giving up before treatment starts. Instead, here are five things that helped me push through.

The Food and Drug Administration has approved the combination use of Venclexta plus Gazyva for the frontline treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.

A recent study showed that postmenopausal women demonstrated a significant reduction in the risk for bladder cancer after quitting smoking, highlighting the need for prevention and cessation programs in older women.

The combination use of Abraxane plus gemcitabine and cisplatin for the treatment of advanced biliary tract cancers prolonged survival, according to phase 2 study findings.

The Food and Drug Administration’s Oncologic Drugs Advisory Committee voted against approving a new drug application for quizartinib for adult patients with relapsed/refractory FLT3-ITD–positive AML.

The Food and Drug Administration approved the combination use of Bavencio plus Inlyta for the first-line treatment of patients with advanced renal cell carcinoma.

Carrying chronic illness can be very difficult, but there are ways to navigate the world without being crushed by the weight of what we cannot control.

The FDA’s Oncologic Drugs Advisory Committee voted in favor of the agency approving pexidartinib to treat adult patients with symptomatic tenosynovial giant cell tumor – a rare, benign lesion that can be locally aggressive and often recurring.

Researchers at Baylor College of Medicine found that a particular subgroup of patients with advanced bladder cancer, identified with a computational tool, responded to immunotherapy.

I hear friends talk about feeling old and resisting the natural process of aging. “Old” for me was a dream and a wish. Now I rejoice in every wrinkle as affirmation that I am getting older. Yahoo. I can’t wait to be 70.

A call to action—We all need to do our part to combat fake or inaccurate health news. Misinformation about any health topic is troubling and potentially dangerous.

Children diagnosed with embryonal brain tumors who have experienced treatment-related hearing loss exhibited greater difficulties reading – in particular, with phonological skills and processing speed, according to study results.

The V Foundation for Cancer Research and ESPN Hall of Fame Sportscaster Dick Vitale are pleased to announce the 14th Annual Dick Vitale Gala raised more than $4.3 million for pediatric cancer research.

A good nurse can make a huge difference for a patient struggling to deal with an illness, not only in comfort, or pain relief, or even in teaching how to manage symptoms or side effects – but in hope and confidence.

The Prostate Cancer Foundation announced the newly revised 2019 Prostate Cancer Patient Guide, a comprehensive resource for diagnosis, treatment, side effects, survivorship, and risk factors for patients and families with a history of prostate cancer.

A breast cancer survivor remembers an inconvenient Mother’s Day phone call as he celebrates five years of being cancer-free.

The Food and Drug Administration approved Cyramza for certain patients with hepatocellular carcinoma.

From National Women's Health Week to today’s top athletes, here’s what’s making headlines in the cancer space this week.

With the growing price of cancer treatment, researchers evaluated the cost-effectiveness of the new standard-of-care in frontline metastatic renal cell carcinoma.

The phase 3 CheckMate 498 trial, designed to compare Opdivo with Temodal for the treatment of patients with newly diagnosed O6-methylguanine-DNA methyltransferase (MGMT)-unmethylated glioblastoma multiforme failed to meet its primary endpoint of increasing overall survival.

Mixing cancer and bipolar illness is not a winning cocktail in the long-term health care industry.

A second ovarian cancer recurrence in three years prompted this review of lessons learned. If I could go back three and a half years and give advice to my newly diagnosed self, what would I say?

Treatment with bb2121 showed promising efficacy and safety among heavily pretreated patients with multiple myeloma, according to interim results published in the New England Journal of Medicine.

How does attitude affect a diagnosis of cancer? Does a positive attitude prolong a person’s life? Does a negative attitude make cancer grow? This survivor discusses how attitude affects cancer in a person’s life.